CDC/NCEH/DLS Fellowship Opportunity at Newborn Screening and Molecular Biology Branch

Overview

*Applications will be reviewed on a rolling-basis.

CDC Office and Location:  A research opportunity is available with the Newborn Screening and Molecular Biology Branch (NSMBB) at the Division of Laboratory Sciences (DLS) within the National Center for Environmental Health (NCEH) at the Centers for Disease Control and Prevention (CDC), located in Atlanta, Georgia.

The Centers for Disease Control and Prevention (CDC) is one of the major operation components of the Department of Health and Human Services. CDC works to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same. For additional information, please go to http://orise.orau.gov/cdc/ or http://www.cdc.gov/.

Research Project: NSMBB is seeking a candidate to contribute to the development of molecular assays to detect newborn disorders which are recommended for screening by the U.S. Department of Health and Human Services and by State Public Health programs. The candidate will be involved in the development of novel laboratory methods and the creation of dried blood spots using human cell lines to mimic samples from affected newborns for targeted disorders.

Learning Objectives: Training will include but not be limited to:

Molecular genetic analysis for newborn screening disorders (e.g., real-time PCR, DNA sequencing, gene copy number analysis, droplet digital PCR, etc.)
Transduction and production of cell lines, including the application of novel CRISPR techniques, to create panels of diverse rare pathogenic variants in the dried blood spot matrix
Devising novel methods for the creation and production of dried blood spot materials for proficiency testing and quality assurance
Participation in all stages of development and validation of molecular assays under ISO standards for providers of proficiency testing materials and proficiency testing programs
Data processing and analysis using complex software and data evaluation procedure
Presentation of results at national conferences and publications
Provide technical support and learn about giving training to state newborn screening programs
Mentor(s): The mentor for this opportunity is Christopher Greene (crg0@cdc.gov). If you have questions about the nature of the research please contact the mentor(s).

Anticipated Appointment Start Date: January 6, 2025. Start date is flexible and will depend on a variety of factors.

Appointment Length: The appointment will initially be for one year but may be renewed upon recommendation of CDC and is contingent on the availability of funds.

Level of Participation: The appointment is full time.

Participant Stipend: Stipend rates may vary based on numerous factors, including opportunity, location, education, and experience. If you are interviewed, you can inquire about the exact stipend rate at that time and if selected, your appointment offer will include the monthly stipend rate.

Citizenship Requirements: This opportunity is available to U.S. citizens only.

ORISE Information: This program, administered by ORAU through its contract with the U.S. Department of Energy (DOE) to manage the Oak Ridge Institute for Science and Education (ORISE), was established through an interagency agreement between DOE and CDC. Participants do not become employees of CDC, DOE or the program administrator, and there are no employment-related benefits. Proof of health insurance is required for participation in this program. Health insurance can be obtained through ORISE.

The successful applicant(s) will be required to comply with Environmental, Safety and Health (ES&H) requirements of the hosting facility, including but not limited to, COVID-19 requirements (e.g. facial covering, physical distancing, testing, vaccination).

Questions: Please visit our Program Website. After reading, if you have additional questions about the application process, please email ORISE.CDC.NCEH@orau.org and include the reference code for this opportunity.
Qualifications
The qualified candidate should have received a master’s or doctoral degree in one of the relevant fields. Degree must have been received within the past five years.

The participant will use the Epstein Barr Virus for cell line transductions. Candidates that are selected will be tested for the presence of antibodies to both VCA and EBNA, which will be required for fellowship eligibility.

An overall GPA of 3.0 or higher on the 4.0 scale is preferred.

The following skills and experiences are desired:

Experience and proficiency in performing molecular techniques (DNA extraction, PCR, real-time PCR, sequencing)
Experience in performing mammalian cell transduction, tissue culture, and aseptic techniques
Proficiency in performing assignments on multiple projects and timelines
Knowledge in human genetics and genomics
Strong organizational skills
Excellent written and oral communication skills